News – PHILADELPHIA – Researchers at the Perelman School of Medicine at the University of Pennsylvania have produced a detailed molecular atlas of lung development, which is expected to be a fundamental reference in future studies on mammalian biology and New treatments for diseases, such as COVID -19, affect the lungs.
The researchers, who published their study in Science, has created an extensive atlas of cell types in developing and adult mouse lungs by measuring the expression of genes in thousands of individual mouse lung cells over their lifetime, covering several cell types and stages of maturity , from early developmental development to adulthood. Analyzing all these data, they predicted thousands of signal interactions among different cell types in the developing lung, confirmed many of these by function tests, and identified several cells and molecular regulators that are critical for normal lung development.
“This study provides institutional information to guide our understanding of how lung activity develops, and how the early postnatal life cycle is a time of rapid change in the lungs to exchange gas. said the auditor general Edward Morrisey, PhD, Professor of Robinette Foundation Medicine, professor of Cell and Developmental Biology, and director of the Penn-CHOP Institute of Lung Biology at Penn Medicine.
The value of new data appears to be valuable in developing future treatments for early-life lung problems, including adequate lung development in premature infants. It could also find a way to find better treatments for asthma and obstructive pulmonary disease (COPD), two of the leading causes of death worldwide.
The study focused mainly on the developmental stages that led to alveoli maturation. These delicate sac-like structures in the lungs contain thin, capillary-filled limbs that direct the exchange of carbon dioxide into the bloodstream for oxygen in incoming air. The average human lung contains hundreds of millions of alveoli, and the total surface area of their gas exchange organs is estimated to be equal to that of a tennis court.
Many human diseases, from birth to old age, disturb these vital structures. But the information on how cells appear and signal to each other to produce alveoli early in life has remained largely a mystery.
The Morrisey team used two relatively new methods called single-cell RNA sequencing and single-cell ATAC sequence to record the expression and access of genes in thousands of individual cells at seven different time points during lung development. in mice. They then analyzed gene activity in each cell type, at each time point, to predict which cells were producing important signal molecules and which were the receptors that received these signals. . In this way they mapped projected interactions among these cells, from which they would identify key factors in alveolar development. Finally, they tested the activity of two of these pathways, the Wnt and Sonic Hedgehog (Shh) pathways, using genetic mouse models to execute the action in specific cell types identified in the single-cell experiments.
A recent finding of the study was the identification of a cell type called alveolar epithelial cell type 1 (AT1), which was already known to help create an alveolar gas exchange interface, as a critical initiator and medium of molecular signals that guide alveolar development. . The researchers also concluded that another cell called secondary signaling myofibroblast (SCMF) plays a key role in guiding the maturation of alveolar structures. In addition, Morrisey’s team identified several transcription factor proteins – which regulate gene activity – as essential for normal alveolar development. Some of these findings have also been proven to occur in human pediatric lungs. The large new database created by the researchers should inform many future studies, including in-depth studies of human lung development.
Molecular details of how alveoli develop will also inform future research aimed at treating disorders that affect these structures. Babies born prematurely often suffer from respiratory distress because their alveoli are not yet fully developed. Pneumonias, which can be caused by bacteria or viruses – including SARS-CoV-2 – and can affect anyone from childhood to old age, are usually ‘reveals a storm of immune molecules and immune cells that damage the alveoli, and destroy the alveolar gas- exchange interface. Similarly, COPD, which may result from long-term cigarette smoking, involves persistent inflammation and deterioration of alveolar structures.
“We hope that our study will provide a framework for a better understanding of the molecular pathways that can be used to promote lung regeneration after traumatic or persistent injury,” Morrisey said.
###
Penn Medicine is one of the world’s leading academic medical institutions, dedicated to the missions of medical education, biomedical research, and excellence in patient care. Penn Medicine is made up of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the first medical school in the country) and the University of Pennsylvania Health System, which together make a $ 7.8 billion venture.
The Perelman School of Medicine has been ranked among the top medical schools in the United States for more than 20 years, according to a U.S. News & World Report study of research-focused medical schools. The School is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $ 425 million awarded in fiscal year 2018.
University of Pennsylvania Health System patient care facilities include: University of Pennsylvania Hospital and Penn Presbyterian Medical Center – which is recognized as one of the leading “Honor Roll” hospitals in the country by US News & World Report – County Hospital Chester; Lancaster General Health; Princeton Health Penn Medicine; and Pennsylvania Hospital, the first hospital in the country, founded in 1751. Additional facilities and initiatives include Penn Good Shepherd Partners, Home Care and Hospice Services, Lancaster Behavioral Health Hospital, and Behavioral Health Home Princeton, among others.
Penn Medicine is led by a talented and dedicated workforce of over 40,000 people. The group also has alliances with major community health systems across both Southeastern Pennsylvania and Southern New Jersey, creating more choices for patients no matter where they live.
Penn Medicine is committed to improving life and health through a variety of community-based programs and activities. In fiscal year 2018, Penn Medicine donated more than $ 525 million to benefit our community.